Sharecare Acquires Virtual Reality Company To Transform

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sharecare Acquires Virtual Reality Company To Transform Patient Engagement and Medical Education

ATLANTA and NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced at Advertising Week 2016 that it is acquiring BioLucid, the leading developer of virtual reality and immersive healthcare technology, including the YOU® VR experience available for HTC VIVE 1 . The acquisition and resulting launch of the Sharecare Reality Lab position Sharecare as the leader in visual health, empowering its users and their loved ones; healthcare providers and patients; educators and students; and pharmaceutical companies and their customers to better communicate and understand medical diagnoses, treatments and patient journeys.

A video accompanying this announcement is available at  http://www.globenewswire.com/NewsRoom/Attachm...296d183aff

Though virtual reality is being used in some niche areas of healthcare—and related hardware is increasingly user-friendly and affordable—the need to purchase additional equipment will continue to be a barrier to entry for many consumers. Therefore, in addition to making the YOU® VR experience available on other virtual reality platforms in the near future, Sharecare is leveraging BioLucid’s health content across its web and mobile applications so people can view–with or without a VR headset–immersive and accurate anatomical simulations of the human body, including disease states, and related treatments and therapies.

“Visual storytelling technologies–particularly virtual reality blended with 360-degree video–have boundless potential in healthcare and patient engagement, yet consumer-facing innovation in VR has been limited mostly to entertainment and gaming,” said Jeff Arnold, chairman and CEO of Sharecare . “By differentiating our platform with BioLucid’s immersive simulation of the human body, we can turn data into actionable, visual intelligence, and make a transformative impact on patient engagement, health literacy, medical education and therapy adherence.”

Sharecare will combine BioLucid’s real-time simulation of the human body with 360-degree video and augmented reality to help patients and providers better understand what each is experiencing by telling the story of patient journeys through scientifically accurate, deep visualizations of conditions, disease states and therapies. From first awareness of symptoms through all stages of treatment and follow-up, these interactive experiences will enable you to view the perspectives of the patient, caregiver or provider at each step in their healthcare journey, fostering empathy and understanding among all healthcare constituents.

Sharecare also is offering its partners–from educational institutions to medical device manufacturers and pharmaceutical companies, and providers–ways to maximize opportunities to obtain unprecedented visual context to discuss healthy physiology, disease and treatment. For example, an Ivy League institution has licensed the BioLucid platform and content so educators can teach students anatomy and physiology in a much more visual and experiential way. Pharmaceutical and medical device marketers can also license the platform and content to create their own custom materials, and sponsor existing information related to organs, treatments and therapies. Finally, for providers who license the platform and content for patient education, the potential is powerful, as more informed patients have better recoveries, reduced readmissions and improved satisfaction; and the visual nature of the platform transcends language barriers for non-English speaking patients.

“As a neurosurgeon, it’s not sufficient simply to tell a patient what’s happening inside their brain, or how a course of treatment will improve their health or even save their life; rather, in many cases, they need to see it to believe it–much less understand it,” said Sanjay Gupta, MD, a practicing neurosurgeon and CNN’s chief medical correspondent . “I’ve long been fascinated with technology’s ability to fuel human optimization, and patient education is an area in which we can greatly improve–that’s why I was immediately intrigued by what Sharecare can achieve with BioLucid’s interactive simulations. I’m looking forward to seeing how visual health can make a positive impact on episodic care, and potentially alter the course of a person’s health journey every day.”

As an extension of Sharecare’s vision to lead in visual health and put all your health in one place, the company is exploring how it can pave the way for the medical record of the future by enabling people to see what’s happening inside their own bodies. Today, even if a patient successfully obtains their medical record, they learn quickly that the two-dimensional stack of paper lacks context and is too clinical for the average patient to understand.

To counter that, as part of each user’s Sharecare profile, the newly formed Sharecare Reality Lab is prototyping a unique “living avatar” that dynamically changes as a person does. Whether it’s an improvement in RealAge, a migraine identified in an AskMD consultation, the seasonal allergies that prompted a telehealth visit, or frictionless data–like heart rate or stress level–captured by sensors and trackers on a smartphone, your avatar will be a comprehensive three-dimensional model of you, detailing how your actions and habits are impacting your health at a micro and macro level–and, in the future, could become your living, breathing medical record. 

As part of the deal, BioLucid’s co-founders Jeff Hazelton, Lawrence Kiey and Dale Park are joining Sharecare, and will retain their office in Sarasota, Florida, under the name Sharecare Reality Lab. Financial terms of the acquisition were not disclosed.

1  VIVE is a first-of-its-kind virtual reality platform developed by HTC and Valve for total immersion in virtual worlds. Designed from the ground up for room-scale VR and true-to-life interactions, VIVE delivers on the promise of VR with technology that’s game changing and content that’s best in class. VIVE has been recognized with over 65 awards and wide critical acclaim since its unveiling in 2015. For more information, please visit  www.vive.com .

About Sharecare Sharecare is a health and wellness engagement solution providing people with personalized resources to help them live their healthiest lives. Nearly 41 million people have shared more than 6 billion data points about their health status and habits with Sharecare, which uses that information to create a comprehensive health profile allowing users to access all of their health resources in one place, and dynamically connect to the knowledge, evidence-based programs and health professionals they need.

Follow us on: Twitter      Facebook      Google+     Instagram      Pinterest      LinkedIn

Media Contact: Jen Martin Hall jen@sharecare.com 404.307.4649

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 537

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 262

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 400

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 403

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 54

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 349

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 512

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

DoubleLine Income Solutions Fund Announces Upcoming Dividend

Updated Category News Views 125

DoubleLine Income Solutions Fund Announces Distribution The DoubleLine Income Solutions Fund, symbolized as DSL on the New York Stock Exchange, has recently declared a distribution of $0.11 per share for the upcoming month. This announcement is significant for investors looking to maximize their income through dividend investments. Details of the Distribution The Board of...

Continue Reading
EQT Corporation Extends Exchange Offers and Consent Solicitations

Updated Category News Views 161

EQT Corporation Extends Exchange Offers and Consent Solicitations EQT Corporation (NYSE: EQT) recently revealed an important update regarding its exchange offers and consent solicitations. This announcement reflects the company’s commitment to providing clarity and opportunities for its stakeholders. The expiration date for these offers has been extended, showcasing...

Continue Reading
Middlefield U.S. Equity Dividend ETF Distributes Key Updates

Updated Category News Views 187

Recent Distributions from Middlefield U.S. Equity Dividend ETF Middlefield U.S. Equity Dividend ETF (TSX: MUSA) has exciting news regarding its distributions for unitholders. These distributions for the fourth quarter promise to benefit investors looking for reliable income through dividends. The Fund has announced a structured schedule that highlights key dates and...

Continue Reading
Bankruptcy Filing Announced for RUAB 'Alinita': Insights

Updated Category News Views 282

Bankruptcy Filing Announced for RUAB 'Alinita' The Panev?žys Regional Court, in a decisive ruling, has transitioned RUAB 'Alinita' into bankruptcy proceedings. This move follows the termination of its restructuring efforts which commenced on a specific date in the recent past. The company, part of the PST Group AB corporate structure, now finds itself looking toward a...

Continue Reading
Gold Prices Remain Strong Amid Fed Policy Concerns

Updated Category News Views 218

Gold Prices Maintain Strength as Market Eyes Federal Reserve Gold continues to command attention in the markets, currently trading close to $2,370. This performance is particularly notable as it stands just below a two-week high, attracting buyers due to its perceived safe-haven quality amid increasing concerns surrounding Federal Reserve's independence. Events...

Continue Reading